Blog

John Donlon, a self-described, “ordinary Joe” who didn’t play sports in college, is doing something fewer than 1,700 people have ever done – swim the English Channel.

Your liver can regenerate after surgical removal or injury with as little as 50% of the original liver remaining, making living-donor liver transplants one of the most successful treatments for those suffering from late-stage liver disease.

When someone is diagnosed with liver disease, a medical team focuses on the patient. Thankfully, others work behind the scenes to ensure the patient’s daily care and well-being.

ALF's former Chairman, Dr. James Boyer, Emeritus Director, Yale Liver Center, has received the International Recognition Award from the European Association for the Study of the Liver (EASL).

Drs. Harvey Alter, Michael Houghton and Charles Rice have received the Nobel Prize in Medicine. Each were also recipients of the ALF Distinguished Scientific Achievement Award.

Did you know NAFLD is the most prevalent disease in human history? It is estimated to affect nearly 2 billion people worldwide and about 100 million individuals in the United States.

Did you know that incidence of hepatitis A and hepatitis C in the United States has increased significantly from 2014 to 2018?

Did you know rates of liver cancer incidence have more than tripled since 1980? During this time, death rates have more than doubled.

Did you know that Biliary Atresia is the most common indication for liver transplant in children?

Dr. Gideon Hirschfield is a leading voice in the field of autoimmune liver disease.

ALF, in partnership with the University of Pittsburgh Medical Center (UPMC), launched The Greatest Gift Initiative to raise awareness about lifesaving living-donor liver transplantation.

UPMC has partnered with the National Kidney Foundation (NKF) and ALF to educate patients on the liver and kidney waiting lists about the benefits of receiving organs from a living donor.